| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear lamina | 2.34e-05 | 2 | 97 | 2 | GO:0160123 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 2.31e-04 | 5 | 97 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CACNA1D XIRP1 MYO1E MYO5B CENPF VASH1 RMDN3 PTPN4 NF1 NKD2 PLEKHG3 FARP1 MYPN KIF18B PALLD | 2.59e-04 | 1099 | 97 | 15 | GO:0008092 |
| GeneOntologyMolecularFunction | alpha-actinin binding | 4.53e-04 | 31 | 97 | 3 | GO:0051393 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 4.83e-04 | 7 | 97 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 8.22e-04 | 9 | 97 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 8.22e-04 | 9 | 97 | 2 | GO:0099626 | |
| MousePheno | abnormal sagittal suture morphology | 9.06e-07 | 14 | 79 | 4 | MP:0003843 | |
| MousePheno | abnormal cranial suture morphology | 3.72e-05 | 67 | 79 | 5 | MP:0002835 | |
| MousePheno | abnormal craniofacial suture morphology | 4.61e-05 | 70 | 79 | 5 | MP:0030229 | |
| MousePheno | abnormal long-term spatial reference memory | 8.16e-05 | 41 | 79 | 4 | MP:0008432 | |
| Domain | Lamin_tail_dom | 1.27e-06 | 5 | 95 | 3 | IPR001322 | |
| Domain | LTD | 1.27e-06 | 5 | 95 | 3 | PF00932 | |
| Domain | - | 1.27e-06 | 5 | 95 | 3 | 2.60.40.1260 | |
| Domain | DUF4414 | 2.56e-05 | 2 | 95 | 2 | IPR025527 | |
| Domain | E3_ub_ligase_SMURF1 | 2.56e-05 | 2 | 95 | 2 | IPR024928 | |
| Domain | DUF4414 | 2.56e-05 | 2 | 95 | 2 | PF14377 | |
| Domain | Glyco_hydro_31_CS | 1.53e-04 | 4 | 95 | 2 | IPR030459 | |
| Domain | NtCtMGAM_N | 1.53e-04 | 4 | 95 | 2 | PF16863 | |
| Domain | Gal_mutarotase_N | 1.53e-04 | 4 | 95 | 2 | IPR031727 | |
| Domain | GLYCOSYL_HYDROL_F31_2 | 2.53e-04 | 5 | 95 | 2 | PS00707 | |
| Domain | HECT | 3.41e-04 | 27 | 95 | 3 | PF00632 | |
| Domain | HECTc | 3.41e-04 | 27 | 95 | 3 | SM00119 | |
| Domain | HECT_dom | 3.41e-04 | 27 | 95 | 3 | IPR000569 | |
| Domain | HECT | 3.41e-04 | 27 | 95 | 3 | PS50237 | |
| Domain | SPOC_C | 3.79e-04 | 6 | 95 | 2 | IPR012921 | |
| Domain | Glyco_hydro_31_AS | 3.79e-04 | 6 | 95 | 2 | IPR030458 | |
| Domain | SPOC | 3.79e-04 | 6 | 95 | 2 | PF07744 | |
| Domain | IQ | 4.70e-04 | 71 | 95 | 4 | PF00612 | |
| Domain | VDCC_a1su_IQ | 5.29e-04 | 7 | 95 | 2 | IPR014873 | |
| Domain | Glyco_hydro_31 | 5.29e-04 | 7 | 95 | 2 | IPR000322 | |
| Domain | GPHH | 5.29e-04 | 7 | 95 | 2 | PF16905 | |
| Domain | Glyco_hydro_31 | 5.29e-04 | 7 | 95 | 2 | PF01055 | |
| Domain | GPHH_dom | 5.29e-04 | 7 | 95 | 2 | IPR031649 | |
| Domain | Ca_chan_IQ | 5.29e-04 | 7 | 95 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 5.29e-04 | 7 | 95 | 2 | PF08763 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 5.29e-04 | 7 | 95 | 2 | PS00129 | |
| Domain | Trefoil | 7.03e-04 | 8 | 95 | 2 | PF00088 | |
| Domain | P_TREFOIL_1 | 7.03e-04 | 8 | 95 | 2 | PS00025 | |
| Domain | P_trefoil_CS | 7.03e-04 | 8 | 95 | 2 | IPR017957 | |
| Domain | PTPc | 8.06e-04 | 36 | 95 | 3 | SM00194 | |
| Domain | P_TREFOIL_2 | 9.00e-04 | 9 | 95 | 2 | PS51448 | |
| Domain | PD | 9.00e-04 | 9 | 95 | 2 | SM00018 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.02e-03 | 39 | 95 | 3 | PS50055 | |
| Domain | VDCCAlpha1 | 1.12e-03 | 10 | 95 | 2 | IPR002077 | |
| Domain | IQ_motif_EF-hand-BS | 1.15e-03 | 90 | 95 | 4 | IPR000048 | |
| Domain | PTPase_domain | 1.18e-03 | 41 | 95 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 1.18e-03 | 41 | 95 | 3 | PF00102 | |
| Domain | IQ | 1.30e-03 | 93 | 95 | 4 | PS50096 | |
| Domain | - | 1.37e-03 | 11 | 95 | 2 | 4.10.110.10 | |
| Domain | P_trefoil_dom | 1.63e-03 | 12 | 95 | 2 | IPR000519 | |
| Domain | FERM-adjacent | 1.93e-03 | 13 | 95 | 2 | IPR014847 | |
| Domain | FA | 1.93e-03 | 13 | 95 | 2 | SM01195 | |
| Domain | FA | 1.93e-03 | 13 | 95 | 2 | PF08736 | |
| Domain | - | 2.57e-03 | 15 | 95 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 2.57e-03 | 15 | 95 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 2.57e-03 | 15 | 95 | 2 | IPR023394 | |
| Domain | Sec7 | 2.93e-03 | 16 | 95 | 2 | SM00222 | |
| Domain | SEC7 | 2.93e-03 | 16 | 95 | 2 | PS50190 | |
| Domain | Sec7_dom | 2.93e-03 | 16 | 95 | 2 | IPR000904 | |
| Domain | Channel_four-helix_dom | 3.06e-03 | 57 | 95 | 3 | IPR027359 | |
| Domain | - | 3.06e-03 | 57 | 95 | 3 | 1.20.120.350 | |
| Domain | Gal_mutarotase_SF_dom | 3.31e-03 | 17 | 95 | 2 | IPR011013 | |
| Domain | EF-hand-dom_pair | 3.46e-03 | 287 | 95 | 6 | IPR011992 | |
| Domain | C2 | 4.50e-03 | 131 | 95 | 4 | PF00168 | |
| Domain | Ez/rad/moesin-like | 5.05e-03 | 21 | 95 | 2 | IPR000798 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | SRRM1 LINC00322 GBF1 MYO1E DIDO1 NF1 LMNA LMNB1 SPEN PALLD PRRC2B REV1 | 6.04e-10 | 361 | 100 | 12 | 26167880 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SRRM1 GBF1 WWP2 LARP1B MAP3K3 KIAA0753 ZNF106 NF1 NKD2 PLEKHG3 SIPA1L2 PALLD ARHGAP21 | 1.17e-06 | 861 | 100 | 13 | 36931259 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | GBF1 MYO1E LARP1B IGF2BP2 FARP1 CD44 BOP1 KIF18B LSM14B SPEN PALLD PRRC2B | 1.19e-06 | 724 | 100 | 12 | 36232890 |
| Pubmed | 1.98e-06 | 503 | 100 | 10 | 16964243 | ||
| Pubmed | SECISBP2L VTN PKP4 DIDO1 SIN3A SBNO2 POP1 PALLD RUBCN ARHGAP21 PRRC2B | 2.81e-06 | 650 | 100 | 11 | 38777146 | |
| Pubmed | SRRM1 CENPF DIDO1 HUWE1 IGF2BP2 NF1 LMNA POP1 BOP1 SPEN PRRC2B | 2.94e-06 | 653 | 100 | 11 | 22586326 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | VTN MYO1E MYO5B CENPF PKP4 DIDO1 IGF2BP2 LMNA LMNB1 PLEKHG3 POP1 CRYBG1 BOP1 LSM14B SPEN | 3.08e-06 | 1257 | 100 | 15 | 36526897 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 5.88e-06 | 569 | 100 | 10 | 30639242 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 18524819 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 17488709 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 11792809 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 9367621 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 37229920 | ||
| Pubmed | The differential expression of lamin epitopes during mouse spermatogenesis. | 8.18e-06 | 2 | 100 | 2 | 7680212 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 25343989 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 38348310 | ||
| Pubmed | The tail domain of lamin B1 is more strongly modulated by divalent cations than lamin A. | 8.18e-06 | 2 | 100 | 2 | 25807068 | |
| Pubmed | CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. | 8.18e-06 | 2 | 100 | 2 | 11402070 | |
| Pubmed | WWP2 overexpression inhibits the antitumor effects of doxorubicin in hepatocellular carcinoma. | 8.18e-06 | 2 | 100 | 2 | 35880837 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 19141474 | ||
| Pubmed | Beta-strand-mediated dimeric formation of the Ig-like domains of human lamin A/C and B1. | 8.18e-06 | 2 | 100 | 2 | 33706103 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 36968271 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 24755485 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 3453101 | ||
| Pubmed | Protein-protein interactions between human nuclear lamins expressed in yeast. | 8.18e-06 | 2 | 100 | 2 | 7628545 | |
| Pubmed | Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion. | 8.18e-06 | 2 | 100 | 2 | 16354706 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 27480812 | ||
| Pubmed | Concentration-dependent lamin assembly and its roles in the localization of other nuclear proteins. | 8.18e-06 | 2 | 100 | 2 | 24523288 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 20356844 | ||
| Pubmed | Cytoskeletal regulation of CD44 membrane organization and interactions with E-selectin. | 8.18e-06 | 2 | 100 | 2 | 25359776 | |
| Pubmed | DCM associated LMNA mutations cause distortions in lamina structure and assembly. | 8.18e-06 | 2 | 100 | 2 | 28844980 | |
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 33570570 | ||
| Pubmed | 8.18e-06 | 2 | 100 | 2 | 31965758 | ||
| Pubmed | β-Amyloid induces nuclear protease-mediated lamin fragmentation independent of caspase activation. | 8.18e-06 | 2 | 100 | 2 | 26876308 | |
| Pubmed | SECISBP2L SRRM1 VTN GBF1 MYO1E WWP2 DIDO1 LARP1B IGF2BP2 LMNB1 FARP1 POP1 BOP1 LSM14B PRRC2B | 8.72e-06 | 1371 | 100 | 15 | 36244648 | |
| Pubmed | Assembly and structure of Lys33-linked polyubiquitin reveals distinct conformations. | 1.26e-05 | 16 | 100 | 3 | 25723849 | |
| Pubmed | SECISBP2L GBF1 MYO5B ZNF407 KIAA0753 PLEKHG3 POP1 EIF2AK1 PALLD | 1.31e-05 | 493 | 100 | 9 | 15368895 | |
| Pubmed | WWP1 DIDO1 HUWE1 MAP3K3 SBNO2 KIAA0753 FARP1 MYPN POP1 CRYBG1 BOP1 ULK2 ARHGAP21 | 1.41e-05 | 1084 | 100 | 13 | 11544199 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | GBF1 TBKBP1 MYO1E WWP1 HUWE1 SBNO2 CASKIN1 PKD1 SIPA1L2 SPEN ULK2 ARHGAP21 PRRC2B | 1.73e-05 | 1105 | 100 | 13 | 35748872 |
| Pubmed | 1.96e-05 | 55 | 100 | 4 | 31985874 | ||
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 2.11e-05 | 400 | 100 | 8 | 35013556 | |
| Pubmed | CENPF PKP4 DIDO1 HUWE1 TENM2 NF1 LMNB1 FARP1 CASKIN1 UNC79 ARHGAP21 PRRC2B | 2.13e-05 | 963 | 100 | 12 | 28671696 | |
| Pubmed | A crucial role for Arf6 in the response of commissural axons to Slit. | 2.16e-05 | 19 | 100 | 3 | 30674481 | |
| Pubmed | 2.39e-05 | 407 | 100 | 8 | 12693553 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 25312645 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 8032679 | ||
| Pubmed | Lco1 is a novel widely expressed lamin-binding protein in the nuclear interior. | 2.45e-05 | 3 | 100 | 2 | 15265697 | |
| Pubmed | A- and B-type lamins are differentially expressed in normal human tissues. | 2.45e-05 | 3 | 100 | 2 | 9243284 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 24293108 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 8838815 | ||
| Pubmed | Partial characterization of murine intestinal maltase-glucoamylase. | 2.45e-05 | 3 | 100 | 2 | 12150962 | |
| Pubmed | Adenovirus protein involved in virus internalization recruits ubiquitin-protein ligases. | 2.45e-05 | 3 | 100 | 2 | 12450395 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 15284226 | ||
| Pubmed | Review: nuclear lamins--structural proteins with fundamental functions. | 2.45e-05 | 3 | 100 | 2 | 10806082 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 28241138 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 21257828 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 26124272 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 30762072 | ||
| Pubmed | Expression of nuclear lamins during mouse preimplantation development. | 2.45e-05 | 3 | 100 | 2 | 3046911 | |
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 10960149 | ||
| Pubmed | 2.45e-05 | 3 | 100 | 2 | 20004208 | ||
| Pubmed | HCELL is the major E- and L-selectin ligand expressed on LS174T colon carcinoma cells. | 2.45e-05 | 3 | 100 | 2 | 16565092 | |
| Pubmed | Dynamics of Lamins B and A/C and Nucleoporin Nup160 during Meiotic Maturation in Mouse Oocytes. | 2.45e-05 | 3 | 100 | 2 | 28374669 | |
| Pubmed | Nuclear titin interacts with A- and B-type lamins in vitro and in vivo. | 2.45e-05 | 3 | 100 | 2 | 16410549 | |
| Pubmed | Nuclear lamins and progerin are dispensable for antioxidant Nrf2 response to arsenic and cadmium. | 2.45e-05 | 3 | 100 | 2 | 28229933 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 2.52e-05 | 410 | 100 | 8 | 26949251 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.53e-05 | 430 | 100 | 8 | 35044719 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SRRM1 VTN MYO5B CENPF HUWE1 IGF2BP2 NF1 LMNA LMNB1 PLEKHG3 BOP1 SPEN | 3.87e-05 | 1024 | 100 | 12 | 24711643 |
| Pubmed | 4.57e-05 | 446 | 100 | 8 | 24255178 | ||
| Pubmed | MYO5B PKP4 HUWE1 KIAA0753 PTPN4 IGF2BP2 PTPRB PTPRH FARP1 CD44 PHLPP1 PRRC2B | 4.88e-05 | 1049 | 100 | 12 | 27880917 | |
| Pubmed | Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. | 4.89e-05 | 4 | 100 | 2 | 21346760 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 28263966 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 17442598 | ||
| Pubmed | Search for type 2 diabetes susceptibility genes on chromosomes 1q, 3q and 12q. | 4.89e-05 | 4 | 100 | 2 | 18259684 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 2680424 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 22260870 | ||
| Pubmed | Disinhibition of the HECT E3 ubiquitin ligase WWP2 by polymerized Dishevelled. | 4.89e-05 | 4 | 100 | 2 | 26701932 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 17550303 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 34696797 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 29753763 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 22527681 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 30968547 | ||
| Pubmed | Lamin proteolysis facilitates nuclear events during apoptosis. | 4.89e-05 | 4 | 100 | 2 | 8978814 | |
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 19602036 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 26490262 | ||
| Pubmed | 4.89e-05 | 4 | 100 | 2 | 18375392 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 5.18e-05 | 333 | 100 | 7 | 32665550 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 5.70e-05 | 231 | 100 | 6 | 16452087 | |
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 5.72e-05 | 26 | 100 | 3 | 26949039 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 8.03e-05 | 774 | 100 | 10 | 15302935 | |
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 28926625 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 11331782 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 28475870 | ||
| Pubmed | Voltage-Gated Ion Channels Are Transcriptional Targets of Sox10 during Oligodendrocyte Development. | 8.14e-05 | 5 | 100 | 2 | 38995010 | |
| Pubmed | DIDO as a Switchboard that Regulates Self-Renewal and Differentiation in Embryonic Stem Cells. | 8.14e-05 | 5 | 100 | 2 | 28330622 | |
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 23374351 | ||
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 11296258 | ||
| Pubmed | Association of emerin with nuclear and cytoplasmic actin is regulated in differentiating myoblasts. | 8.14e-05 | 5 | 100 | 2 | 12670476 | |
| Pubmed | Reciprocal knock-in mice to investigate the functional redundancy of lamin B1 and lamin B2. | 8.14e-05 | 5 | 100 | 2 | 24672053 | |
| Pubmed | 8.14e-05 | 5 | 100 | 2 | 22021370 | ||
| Interaction | NALCN interactions | 5.28e-07 | 14 | 99 | 4 | int:NALCN | |
| Interaction | DVL1 interactions | 7.94e-07 | 151 | 99 | 8 | int:DVL1 | |
| Interaction | KIF23 interactions | FLG SRRM1 VTN MYO1E MYO5B HUWE1 TEX14 LARP1B MAP3K4 IGF2BP2 LMNA SLC15A4 FARP1 CD44 PHLPP1 BOP1 ARHGAP21 | 1.03e-05 | 1031 | 99 | 17 | int:KIF23 |
| Interaction | YWHAH interactions | SRRM1 GBF1 MYO1E HUWE1 LARP1B MAP3K3 KIAA0753 RMDN3 ZNF106 PTPN4 NF1 NKD2 PLEKHG3 SIPA1L2 PALLD RUBCN ARHGAP21 | 2.43e-05 | 1102 | 99 | 17 | int:YWHAH |
| Interaction | YWHAQ interactions | VTN GBF1 WWP1 WWP2 LARP1B MAP3K3 RMDN3 ZNF106 PTPN4 NF1 NKD2 LMNA LMNB1 PLEKHG3 SIPA1L2 UNC79 ARHGAP21 | 2.92e-05 | 1118 | 99 | 17 | int:YWHAQ |
| Interaction | MYPN interactions | 4.37e-05 | 40 | 99 | 4 | int:MYPN | |
| Interaction | SRPK2 interactions | SRRM1 LINC00322 GBF1 MYO1E WWP2 DIDO1 LMNA LMNB1 POP1 BOP1 SPEN PALLD PRRC2B | 4.86e-05 | 717 | 99 | 13 | int:SRPK2 |
| Interaction | SCN11A interactions | 5.01e-05 | 15 | 99 | 3 | int:SCN11A | |
| Interaction | CAPZA2 interactions | MYO1E MYO5B WWP2 PKP4 ZNF106 PLEKHG3 FARP1 MYPN CRYBG1 ARHGAP21 | 5.05e-05 | 430 | 99 | 10 | int:CAPZA2 |
| Interaction | SCN5A interactions | 8.31e-05 | 47 | 99 | 4 | int:SCN5A | |
| GeneFamily | Lamins | 3.35e-05 | 3 | 61 | 2 | 612 | |
| GeneFamily | C2 and WW domain containing | 6.69e-05 | 4 | 61 | 2 | 838 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 2.33e-04 | 7 | 61 | 2 | 1350 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.48e-04 | 206 | 61 | 5 | 682 | |
| GeneFamily | Synaptotagmins | 1.47e-03 | 17 | 61 | 2 | 765 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.26e-03 | 21 | 61 | 2 | 813 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 2.95e-03 | 24 | 61 | 2 | 654 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.45e-03 | 26 | 61 | 2 | 253 | |
| GeneFamily | EF-hand domain containing | 6.38e-03 | 219 | 61 | 4 | 863 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 8.44e-03 | 41 | 61 | 2 | 1298 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.03e-02 | 718 | 61 | 7 | 28 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.24e-02 | 50 | 61 | 2 | 1293 | |
| GeneFamily | PDZ domain containing | 1.47e-02 | 152 | 61 | 3 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 1.68e-02 | 160 | 61 | 3 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.71e-02 | 161 | 61 | 3 | 593 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.25e-07 | 200 | 99 | 7 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-06 | 182 | 99 | 6 | 0fc45214f0b0766f69be6eff69cc4bec574023aa | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.64e-06 | 185 | 99 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.75e-06 | 186 | 99 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 189 | 99 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 189 | 99 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.37e-06 | 198 | 99 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | 5.69e-06 | 200 | 99 | 6 | a02fa5b3c4723a6eaa3c685588666c710478dd25 | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 5.69e-06 | 200 | 99 | 6 | 4e489ecf472857357d45e9f6c7a812aa48b72ebf | |
| ToppCell | (24)_B_cell_cycling|World / shred on Cell_type and subtype | 6.02e-06 | 202 | 99 | 6 | a7c9b6b173701348ba35fbb975e0bdd3c1f1d5fe | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3-Excitatory_Neuron.Slc17a7.Pvrl3-Nos1_(CA3_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.95e-06 | 128 | 99 | 5 | 9128b633879d21de2ebe651384cfec6d2c3c2932 | |
| ToppCell | Dividing_Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.01e-05 | 148 | 99 | 5 | 66b51aa6690bf8fbc90fa5a6f86191703e2d5046 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-05 | 154 | 99 | 5 | 692eb053620db86d301b09bf743ab45fccc245be | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 161 | 99 | 5 | e227f7b711475624cf80e77f235b1783d88d57b4 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 161 | 99 | 5 | 8280a029026c272cae9649b27575831b0dd4e242 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.19e-05 | 163 | 99 | 5 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.01e-05 | 171 | 99 | 5 | 6e7ade1d14a3ec4c566476aac3eb509bd2661e39 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-05 | 171 | 99 | 5 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK-NK_CD16|GI_small-bowel / Manually curated celltypes from each tissue | 4.12e-05 | 172 | 99 | 5 | 701de463f85aaad3a4b36a0d5fbc416406620089 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.24e-05 | 173 | 99 | 5 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.24e-05 | 173 | 99 | 5 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.35e-05 | 174 | 99 | 5 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.35e-05 | 174 | 99 | 5 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | NS-moderate-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.72e-05 | 177 | 99 | 5 | de1ffe3df76100d46ca158bdd2fea2ebbd4656b4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 178 | 99 | 5 | ee674e379ee57e40eb2560ff5ed4c13d8db7ed9d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 178 | 99 | 5 | 6c45bf197d6c1be0ef7d3a644c0062acf1e24e4d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 178 | 99 | 5 | cd85dcefe94ee742db64b63e105e13532321894a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-05 | 179 | 99 | 5 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.98e-05 | 179 | 99 | 5 | e67ad7ab04d0c1309296f57c1f53c5ca14c213fe | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.12e-05 | 180 | 99 | 5 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-05 | 180 | 99 | 5 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 180 | 99 | 5 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 180 | 99 | 5 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 5.25e-05 | 181 | 99 | 5 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 182 | 99 | 5 | bc6a120dedc813c58baac1428c39851a07b71ba7 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.39e-05 | 182 | 99 | 5 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.39e-05 | 182 | 99 | 5 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.53e-05 | 183 | 99 | 5 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease group and Cell class | 5.53e-05 | 183 | 99 | 5 | 09c2b4e630f1c338f02c1242e3598e870d6b0a28 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 186 | 99 | 5 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 186 | 99 | 5 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.44e-05 | 189 | 99 | 5 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 190 | 99 | 5 | 31de1727822e9818652946dfb962daee77ffad68 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.61e-05 | 190 | 99 | 5 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | (02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint | 6.61e-05 | 190 | 99 | 5 | 53f017a11ca5ebe9025558e12cedc409cab2e5aa | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 6.61e-05 | 190 | 99 | 5 | 451eaceb0cb0ec6cfcae00253c0e5c92a168c2f3 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-05 | 191 | 99 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | COVID-19_Moderate-pDC|World / disease group, cell group and cell class | 6.77e-05 | 191 | 99 | 5 | 93adfbc0b22f6006d6d5ad67a99e33cbe9e1dfe9 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 191 | 99 | 5 | be2fe2583bdcee0b35c43a347da9c4adb93e30e0 | |
| ToppCell | COVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class | 6.77e-05 | 191 | 99 | 5 | 9d0ffa65c547e20b4076fd97776d7738cbd453ec | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.77e-05 | 191 | 99 | 5 | 4cebaf31d4f09f4ab273a819ad5cbff7d9a9b341 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-05 | 191 | 99 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-05 | 191 | 99 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.11e-05 | 193 | 99 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.11e-05 | 193 | 99 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-05 | 193 | 99 | 5 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.11e-05 | 193 | 99 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 7.29e-05 | 194 | 99 | 5 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 7.47e-05 | 195 | 99 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-05 | 196 | 99 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-05 | 196 | 99 | 5 | eb8c9a4a5eb21d43ff7b25deae5896c236f669b9 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue | 7.65e-05 | 196 | 99 | 5 | f7e5a7fad4547e8ab9ab8b140239281832fb4260 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 7.65e-05 | 196 | 99 | 5 | a3b077e82b1550eb328c84b567b60179001f9a77 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 7.65e-05 | 196 | 99 | 5 | 1868ad537b7f04cdad0a0c8282aadbc4f257a722 | |
| ToppCell | CD8+_Memory_T_cell-CV-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.84e-05 | 197 | 99 | 5 | 9fe3d53346a95c1bbb0fc6a2f2e974889873424b | |
| ToppCell | CV-Moderate-3|CV / Virus stimulation, Condition and Cluster | 7.84e-05 | 197 | 99 | 5 | 7031286e300eaccf73b927939f8de3a9d2d5fc74 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.03e-05 | 198 | 99 | 5 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.03e-05 | 198 | 99 | 5 | eb5407908f1e43b5775d50006cc6c71e90b73660 | |
| ToppCell | mild-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.03e-05 | 198 | 99 | 5 | 1d20fc9948965de52a98f758035edfdd12cafc5f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.03e-05 | 198 | 99 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.03e-05 | 198 | 99 | 5 | 08e031cacded172bf85c8541b4724f97f19a0b99 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.03e-05 | 198 | 99 | 5 | 56a39e44c6f97b8093e3a3815b94a1ddf906f59d | |
| ToppCell | Caecum-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 8.03e-05 | 198 | 99 | 5 | d2def132f3efe9305a5501a96ec82efb1f02c3f7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.03e-05 | 198 | 99 | 5 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK|COVID-19_Mild / Disease group, lineage and cell class | 8.03e-05 | 198 | 99 | 5 | 52f9ed4b89bbce53104179bee194c0456c4b7a3c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.03e-05 | 198 | 99 | 5 | a89de373e4287a104d4df2c40fb0e406d729b1df | |
| ToppCell | mLN-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 8.22e-05 | 199 | 99 | 5 | c81a194f8c2f120c6c4d74857912865a3c2fe1e7 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.22e-05 | 199 | 99 | 5 | b03539908131308d7bf5036e78c4c840a6a79a17 | |
| ToppCell | (2)_B_cell-(24)_B_cell_cycling|(2)_B_cell / shred on Cell_type and subtype | 8.22e-05 | 199 | 99 | 5 | d5a9a8a71c4de8cbcef947943f60838731bc640b | |
| ToppCell | COVID-19_Moderate-NK|COVID-19_Moderate / disease group, cell group and cell class | 8.22e-05 | 199 | 99 | 5 | e0e83ba511957be9ad3413460dcb6b7d7b65dd18 | |
| ToppCell | control-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.22e-05 | 199 | 99 | 5 | 8aca7775b3d34fd26c7b23ddb23f5f2df72684b0 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.22e-05 | 199 | 99 | 5 | 7d071c88a003babf6dbdb84dde561fc03c92f375 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.22e-05 | 199 | 99 | 5 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | (1)_T_cell-(18)_cycling_gd_T|(1)_T_cell / shred on Cell_type and subtype | 8.22e-05 | 199 | 99 | 5 | 9369d0e4efe809e3e8757294ebebba5a47b30528 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 8.41e-05 | 200 | 99 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK|COVID-19_Mild / Disease, condition lineage and cell class | 8.41e-05 | 200 | 99 | 5 | 885fcb6c6c744f89fc983a617303e6f57126d908 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 8.41e-05 | 200 | 99 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Sigmoid-(1)_T_cell-(18)_cycling_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 8.41e-05 | 200 | 99 | 5 | 6e367abd1a4b87e20eb9095b8337723163e8bbae | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.41e-05 | 200 | 99 | 5 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|Sigmoid / Region, Cell class and subclass | 8.41e-05 | 200 | 99 | 5 | 9769185abae084ffac36420c749625e679b70ca8 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.10e-04 | 111 | 99 | 4 | 45a8e069369fdc7358135bf2229defbee1ac2600 | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-04 | 118 | 99 | 4 | 6053e19d040fb394f9c270361af07b0c5a4d47db | |
| ToppCell | LPS-IL1RA-Myeloid-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-04 | 118 | 99 | 4 | 811e8521129914eef46785a4227c1860e77d9096 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-04 | 137 | 99 | 4 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_stem_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.48e-04 | 137 | 99 | 4 | ed81624b9167255ce88dcf6ad7f1636376ea0525 | |
| Disease | Autism Spectrum Disorders | 7.90e-06 | 85 | 94 | 5 | C1510586 | |
| Disease | autosomal recessive Emery-Dreifuss muscular dystrophy 3 (implicated_via_orthology) | 3.01e-05 | 3 | 94 | 2 | DOID:0070248 (implicated_via_orthology) | |
| Disease | congenital muscular dystrophy due to LMNA mutation (implicated_via_orthology) | 3.01e-05 | 3 | 94 | 2 | DOID:0110640 (implicated_via_orthology) | |
| Disease | familial partial lipodystrophy type 2 (implicated_via_orthology) | 3.01e-05 | 3 | 94 | 2 | DOID:0070202 (implicated_via_orthology) | |
| Disease | autosomal dominant Emery-Dreifuss muscular dystrophy 2 (implicated_via_orthology) | 3.01e-05 | 3 | 94 | 2 | DOID:0070247 (implicated_via_orthology) | |
| Disease | propionic acid measurement | 6.00e-05 | 4 | 94 | 2 | EFO_0010525 | |
| Disease | dilated cardiomyopathy 1A (implicated_via_orthology) | 6.00e-05 | 4 | 94 | 2 | DOID:0110425 (implicated_via_orthology) | |
| Disease | Heart Block | 6.00e-05 | 4 | 94 | 2 | C0018794 | |
| Disease | Auriculo-Ventricular Dissociation | 6.00e-05 | 4 | 94 | 2 | C0004331 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 9.30e-05 | 447 | 94 | 8 | EFO_0000694, MONDO_0100096 | |
| Disease | Movement Disorders | 1.08e-04 | 29 | 94 | 3 | C0026650 | |
| Disease | interleukin 17 receptor B measurement | 1.49e-04 | 6 | 94 | 2 | EFO_0008176 | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 1.49e-04 | 6 | 94 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | Dermatitis, Atopic | 2.07e-04 | 36 | 94 | 3 | C0011615 | |
| Disease | Eczema, Infantile | 2.07e-04 | 36 | 94 | 3 | C0086196 | |
| Disease | Esophageal carcinoma | 2.09e-04 | 7 | 94 | 2 | C0152018 | |
| Disease | forced expiratory volume | CACNA1D BNC2 LCORL WWP2 ZKSCAN2 KIAA0753 IGF2BP2 MYPN BOP1 PRRC2B | 2.11e-04 | 789 | 94 | 10 | EFO_0004314 |
| Disease | body surface area | 2.15e-04 | 643 | 94 | 9 | EFO_0022196 | |
| Disease | cerebrovascular disease (is_implicated_in) | 2.78e-04 | 8 | 94 | 2 | DOID:6713 (is_implicated_in) | |
| Disease | lung volume | 2.78e-04 | 8 | 94 | 2 | EFO_0600046 | |
| Disease | progeria (implicated_via_orthology) | 2.78e-04 | 8 | 94 | 2 | DOID:3911 (implicated_via_orthology) | |
| Disease | treatment-resistant hypertension | 4.16e-04 | 109 | 94 | 4 | EFO_1002006 | |
| Disease | vital capacity | BNC2 MYO1E LCORL WWP2 WNT9A ZKSCAN2 TENM2 ZNF106 IGF2BP2 MYPN SYT14 BOP1 | 5.56e-04 | 1236 | 94 | 12 | EFO_0004312 |
| Disease | Parkinson disease | 5.77e-04 | 321 | 94 | 6 | MONDO_0005180 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 6.49e-04 | 12 | 94 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | body weight | SECISBP2L CACNA1B MGAM LCORL WNT9A HUWE1 SBNO2 OPRM1 IGF2BP2 SYT14 PKD1 UNC79 | 6.63e-04 | 1261 | 94 | 12 | EFO_0004338 |
| Disease | visceral adipose tissue measurement | 8.85e-04 | 481 | 94 | 7 | EFO_0004765 | |
| Disease | diverticular disease | 9.66e-04 | 236 | 94 | 5 | EFO_0009959 | |
| Disease | smoking status measurement | CACNA1D BNC2 GBF1 WWP2 GATB ZNF407 TENM2 SYT14 UNC79 PRRC2B DNMT3B | 1.16e-03 | 1160 | 94 | 11 | EFO_0006527 |
| Disease | phosphatidylcholine 38:3 measurement | 1.17e-03 | 16 | 94 | 2 | EFO_0010385 | |
| Disease | response to homoharringtonine, cytotoxicity measurement | 1.32e-03 | 17 | 94 | 2 | EFO_0006952, EFO_0006996 | |
| Disease | glucose measurement | 1.38e-03 | 380 | 94 | 6 | EFO_0004468 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.44e-03 | 152 | 94 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | alkaline phosphatase measurement | SELE WWP2 GATB LARP1B SBNO2 NF1 CASKIN1 PKD1 LSM14B ARHGAP21 | 1.47e-03 | 1015 | 94 | 10 | EFO_0004533 |
| Disease | Contact Dermatitis | 1.53e-03 | 71 | 94 | 3 | C0011616 | |
| Disease | Contact hypersensitivity | 1.53e-03 | 71 | 94 | 3 | C0162351 | |
| Disease | pulse pressure measurement | CACNA1D BNC2 MYO1E LCORL WWP2 SMOC2 KIAA0753 MYPN PKD1 ROBO3 PALLD DNMT3B | 1.55e-03 | 1392 | 94 | 12 | EFO_0005763 |
| Disease | Craniofacial Abnormalities | 1.58e-03 | 156 | 94 | 4 | C0376634 | |
| Disease | non-melanoma skin carcinoma | 1.61e-03 | 265 | 94 | 5 | EFO_0009260 | |
| Disease | prion disease | 1.66e-03 | 19 | 94 | 2 | EFO_0004720 | |
| Disease | alcohol consumption measurement | SECISBP2L CACNA1D MGAM LCORL TENM2 OPRM1 PTPRB NF1 FARP1 SYT14 DNMT3B | 1.99e-03 | 1242 | 94 | 11 | EFO_0007878 |
| Disease | muscular dystrophy (implicated_via_orthology) | 2.03e-03 | 21 | 94 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | Etat Marbre | 2.43e-03 | 23 | 94 | 2 | C0266487 | |
| Disease | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement | 2.65e-03 | 24 | 94 | 2 | EFO_0006821, EFO_0006826 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RRIGSVTSRQTSNPN | 286 | Q99569 | |
| SQSPFRRSHGQVQRV | 571 | Q14137 | |
| EHESRTQNGRSFQRT | 31 | P20292 | |
| QRGLQRQPSSSRRDS | 341 | P49682 | |
| RNNNSVSSRERHRPS | 106 | Q9UBC3 | |
| SSLRSRNRHSANPNP | 481 | Q6ZN30 | |
| ADHPSRLNQANSSGR | 321 | Q9BYV8 | |
| HRRGAPTGSTSNQIR | 26 | O75879 | |
| SHGQSGPRSASRQTR | 1531 | P20930 | |
| GPRSASRQTRNEEQS | 1536 | P20930 | |
| SAREQSRHGSRNPRS | 1621 | P20930 | |
| PHQQSHQESTRGRSA | 2391 | P20930 | |
| PSTRGRQGSRHEQAQ | 3081 | P20930 | |
| QERGRSQERRQPSSS | 2106 | Q00975 | |
| TPNHRNSTFTQEGTR | 396 | P29074 | |
| HNGTGTVRRRPASEQ | 1171 | Q8WXD9 | |
| TVPASVSHLRGSNRN | 1171 | P23467 | |
| TRIRQNTRDHPSTAN | 366 | P35372 | |
| QRSRGRASSHSSQTQ | 396 | P02545 | |
| RGNGTTRRNPTSHRA | 366 | Q9BX40 | |
| VRSRNSRNHTVNSGG | 76 | Q6ZU64 | |
| SRNHNTIGTRRQDPV | 1581 | O43451 | |
| FSRNHNTIGTRRQDP | 2476 | O43451 | |
| PSSENSVAGRLHRNR | 251 | Q8N3X6 | |
| HRGQSGRAPTQASIR | 176 | Q96PT3 | |
| HQQGTPRASNRSCAI | 571 | P20700 | |
| STFPQRSQHRGQSSQ | 986 | Q5VYM1 | |
| RSQHRGQSSQHTALP | 991 | Q5VYM1 | |
| VSRHARTSQNDRPRQ | 131 | Q8N8A8 | |
| AVRQPQNGSVRCSHS | 306 | P16581 | |
| HNTSTAGGRLDRQPR | 351 | Q8N9Z9 | |
| PQRAQRGDHSSREQG | 166 | Q9Y6M1 | |
| SQRTLRQLTANTGHT | 2546 | Q7Z6Z7 | |
| EILTRGNRNRTQHPT | 201 | Q86Y91 | |
| GNRNRTQHPTDANAT | 206 | Q86Y91 | |
| QEPQGRASHLQARSR | 271 | Q969F2 | |
| SHRQSQQGSRGQNRP | 136 | Q9UBG3 | |
| LGEHASRRPQDNRST | 86 | Q8WX93 | |
| PGTSRQRQTRVNPHS | 51 | Q99575 | |
| QRPHFQSSGAQQESR | 141 | Q8N8I6 | |
| SHLSSNSQRTPIRRD | 226 | P49454 | |
| NRNDVTGGRRDPNHS | 536 | P16070 | |
| QHLTRRNSSQRPSAI | 561 | Q9BQI3 | |
| RQESQPHSGSSRRES | 231 | Q6ZN03 | |
| SRTSLERQAPHRGNT | 896 | Q9Y4F1 | |
| ASQASNHRDPRQARR | 1551 | Q9BTC0 | |
| RPSQHTRSRQVTSAQ | 116 | P05111 | |
| RPRTSSQHASRGGQS | 1461 | Q92538 | |
| TNSSPRHTDIRGQRN | 281 | Q9Y4K1 | |
| RHTDIRGQRNTPASS | 286 | Q9Y4K1 | |
| SSLHQSVPNNGSERR | 231 | Q92622 | |
| RDHQRSRANGVPTSR | 561 | Q8N697 | |
| ETHRRPSPQRNTTND | 706 | Q8N0W4 | |
| DRRDSLQQTNTTHRP | 1696 | Q01668 | |
| TQRRAPSTGIHQRSI | 51 | Q9H7T9 | |
| ANKPTHNNRRNDTRS | 106 | Q659C4 | |
| RSRHLSVSSQNPGRS | 161 | Q99759 | |
| PRGQNQRSQTSRTSS | 411 | Q3SYA9 | |
| QQLHSLQGRRSSRAP | 4241 | P98161 | |
| RRSSGERNDAAPTNH | 6 | Q8N9Y4 | |
| QGTNSRRPNETAREH | 681 | Q9Y283 | |
| STKHQRNNVGRPASR | 96 | Q9Y6R4 | |
| PTSSARHNSIRRQLN | 161 | Q86SS6 | |
| TPARYREHRSNSQQG | 556 | Q4G112 | |
| KRTQRHGRSQSLPNS | 36 | Q96TC7 | |
| THNSRLPLADSRQRN | 106 | Q8NB59 | |
| ETSRIQNTSSQGRPR | 856 | Q8IWB6 | |
| GSLRSRHLPNSNNNS | 51 | A1L390 | |
| LGSPSAQREHRQNTA | 116 | Q8NDX1 | |
| HTANRQQRSTSPVAR | 181 | Q9Y252 | |
| TQPHTRNSDSRGGRQ | 556 | Q9Y252 | |
| RGLHPIRQRSNSDVT | 151 | Q9P2F8 | |
| SQNGCQIRRHPTGTT | 421 | Q96ST3 | |
| TRAVGRRRSHQGQQS | 196 | Q96M53 | |
| RRRSHQGQQSQSSSR | 201 | Q96M53 | |
| QQFGRTHRSNQVSAP | 836 | Q9Y2G9 | |
| SSHRSRNSNRGSVVP | 161 | Q93073 | |
| NRNSLTNRRSQIHAP | 271 | Q9NT68 | |
| RNHNIANTRRQDPAS | 1556 | P14410 | |
| ERGRQSQPHSKSRVQ | 521 | Q2KHM9 | |
| PRRHGERRNSNLSQT | 611 | P35498 | |
| ATGEQSPGARSRHRQ | 206 | O00308 | |
| RSRSPHSSQSRNQSP | 241 | Q96T58 | |
| QASTRSRPQSHSQSR | 271 | B3KS81 | |
| QSGSPNKQRDHSRSR | 391 | B3KS81 | |
| QSTRNTDALRNPHRT | 281 | Q9UBZ9 | |
| RGHAESTSNRQPRKQ | 431 | Q9H3U7 | |
| TRHSPTPQQSNRTRK | 411 | Q8IYB3 | |
| SRSQSRSQSQRPGQK | 1366 | Q96MS0 | |
| EHLQRQNSSNGRISP | 36 | Q6FIF0 | |
| RNRNTDQSGRHQPSL | 251 | Q8NBB4 | |
| RQTLGGNNSQRTHPE | 186 | Q96K75 | |
| GRTRHGSASQVQKQR | 2811 | P21359 | |
| SSQHPEQTGRTRRSG | 926 | Q5JSZ5 | |
| NVHGSPRSAVVRRSN | 426 | Q8IYT8 | |
| RGHNTQSRVVTRPCQ | 326 | O14904 | |
| ETGRLRQQVSSPVHR | 126 | Q63HK3 | |
| RRANGSVAPQERSHN | 1621 | O60346 | |
| TLQAAHGNSVTSRPR | 401 | Q9C0G0 | |
| STFSNSNQRRIRHTG | 151 | B4DXR9 | |
| PRSDTSNNHSGRLQL | 6 | Q9H0M0 | |
| QRAQSSPHRRNSRSE | 326 | Q7L8A9 | |
| QGRRRSTSHDRVPQS | 436 | Q5T5U3 | |
| QARSGGQRHSPLSQR | 326 | A7MCY6 | |
| TRNATTAHNPVRNLR | 201 | Q9HD43 | |
| SQRGHSRGRNQNSRR | 381 | P04004 | |
| GVQLSQREPQSRHRE | 1156 | Q702N8 | |
| RNTRNRENSPSSQSA | 1271 | Q9H2Y7 | |
| KRHESRGNQSGRSPN | 871 | Q9UNY4 | |
| GRSRQNSATRPDNSE | 1546 | Q9P2D8 | |
| KNSRPTRRNTTQNTG | 926 | Q12965 | |
| GHRRNPSNQSSLESD | 1096 | Q9ULV0 | |
| HRGNNERSRAEPSSN | 26 | Q86TC9 |